Role of local treatment including radiotherapy in Barcelona Clinic of Liver Cancer stage C patients: a nationwide cohort analysis in South Korea

References

• El-SeragHBRudolphKLHepatocellular carcinoma: epidemiology and molecular carcinogenesisGastroenterology200713272557257617570226
   PubMed Web of Science ®Google Scholar
• HanKKimJHKoGYGwonDISungKBTreatment of hepatocellular carcinoma with portal venous tumor thrombosis: a comprehensive reviewWorld J Gastroenterol201622140741626755886
   PubMed Web of Science ®Google Scholar
• LlovetJMBrúCBruixJPrognosis of hepatocellular carcinoma: the BCLC staging classificationSemin Liver Dis199919332933810518312
   PubMed Web of Science ®Google Scholar
• FornerAReigMERodriguez de LopeCBruixJde LopeCRCurrent strategy for staging and treatment: the BCLC update and future prospectsSemin Liver Dis20103001617420175034
   PubMedGoogle Scholar
• NanashimaATobinagaSKunizakiMStrategy of treatment for hepatocellular carcinomas with vascular infiltration in patients undergoing hepatectomyJ Surg Oncol2010101755756320213729
   PubMed Web of Science ®Google Scholar
• LlovetJMRicciSMazzaferroVSorafenib in advanced hepatocellular carcinomaN Engl J Med2008359437839018650514
   PubMed Web of Science ®Google Scholar
• ChengALKangYKChenZEfficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a Phase III randomised, double-blind, placebo-controlled trialLancet Oncol2009101253419095497
   PubMed Web of Science ®Google Scholar
• RimCHYoonWSLeaflet manual of external beam radiation therapy for hepatocellular carcinoma: a review of the indications, evidences, and clinical trialsOnco Targets Ther2018112865287429844684
   PubMed Web of Science ®Google Scholar
• YoonSMRyooBYLeeSJEfficacy and safety of transarterial chemoembolization plus external beam radiotherapy vs sorafenib in hepatocellular carcinoma with macroscopic vascular invasion: a randomized clinical trialJAMA Oncol20184566166929543938
   PubMed Web of Science ®Google Scholar
• National Cancer Information Center of Korea Available from: https://www.cancer.go.kr/lay1/S1T639C641/contents.doAccessed September 7, 2018
   Google Scholar
• SeoYSKimMSKangJKThe clinical utilization of radiation therapy in Korea between 2011 and 2015Cancer Res Treat201850234535528449574
   PubMed Web of Science ®Google Scholar
• European Association for the Study of the LiverEASL clinical practice guidelines: management of hepatocellular carcinomaJ Hepatol201869118223629628281
   PubMed Web of Science ®Google Scholar
• BruixJShermanMAmerican Association for the Study of Liver DiseasesManagement of hepatocellular carcinoma: an updateHepatology2011531020102221374666
   PubMed Web of Science ®Google Scholar
• HawkinsMADawsonLARadiation therapy for hepatocellular carcinoma: from palliation to cureCancer200610681653166316541431
   PubMed Web of Science ®Google Scholar
• RimCHKimCYYangDSYoonWSComparison of radiation therapy modalities for hepatocellular carcinoma with portal vein thrombosis: a meta-analysis and systematic reviewRadiother Oncol2018129111212229233562
   PubMed Web of Science ®Google Scholar
• RimCHSeongJApplication of radiotherapy for hepatocellular carcinoma in current clinical practice guidelinesRadiat Oncol J201634316016727730805
   PubMedGoogle Scholar
• NaultJCThe end of almost 10 years of negative RCTs in advanced hepatocellular carcinomaLancet2017389100644627932228
   PubMed Web of Science ®Google Scholar
• JamesSRaoSVGrangerCBRegistry-based randomized clinical trials – a new clinical trial paradigmNat Rev Cardiol201512531231625781411
   PubMed Web of Science ®Google Scholar
• ChalkidouKTunisSWhicherDFowlerRZwarensteinMThe role for pragmatic randomized controlled trials (pRCTs) in comparative effectiveness researchClin Trials20129443644622752634
   PubMed Web of Science ®Google Scholar
• ChoiGHShimJHKimMJSorafenib alone versus sorafenib combined with transarterial chemoembolization for advanced-stage hepatocellular carcinoma: results of propensity score analysesRadiology2013269260361123864102
   PubMed Web of Science ®Google Scholar
• WuFXChenJBaiTThe safety and efficacy of transarterial chemoembolization combined with sorafenib and sorafenib monotherapy in patients with BCLC stage B/C hepatocellular carcinomaBMC Cancer201717164528899349
   PubMedGoogle Scholar
• NakazawaTHidakaHShibuyaAOverall survival in response to sorafenib versus radiotherapy in unresectable hepatocellular carcinoma with major portal vein tumor thrombosis: propensity score analysisBMC Gastroenterol20141418424886354
   PubMed Web of Science ®Google Scholar
• TanakaYNakazawaTKomoriSRadiotherapy for patients with unresectable advanced hepatocellular carcinoma with invasion to intrahepatic large vessels: efficacy and outcomesJ Gastroenterol Hepatol201429235235723869689
   PubMed Web of Science ®Google Scholar
• MinagawaMMakuuchiMTreatment of hepatocellular carcinoma accompanied by portal vein tumor thrombusWorld J Gastroenterol200612477561756717171782
   PubMed Web of Science ®Google Scholar
• LiuLZhaoYQiXTransjugular intrahepatic portosystemic shunt for symptomatic portal hypertension in hepatocellular carcinoma with portal vein tumor thrombosisHepatol Res201444662163023679937
   PubMed Web of Science ®Google Scholar
• HuangYJHsuHCWangCYThe treatment responses in cases of radiation therapy to portal vein thrombosis in advanced hepatocellular carcinomaInt J Radiat Oncol Biol Phys20097341155116318760547
   PubMed Web of Science ®Google Scholar
• KimDYParkWLimDHThree-dimensional conformal radiotherapy for portal vein thrombosis of hepatocellular carcinomaCancer2005103112419242615822130
   PubMed Web of Science ®Google Scholar
• HasegawaKMakuuchiMKokudoNImpact of histologically confirmed lymph node metastases on patient survival after surgical resection for hepatocellular carcinoma: report of a Japanese nationwide surveyAnn Surg2014259116617023532111
   PubMed Web of Science ®Google Scholar
• ZengZCTangZYFanJConsideration of role of radiotherapy for lymph node metastases in patients with HCC: retrospective analysis for prognostic factors from 125 patientsInt J Radiat Oncol Biol Phys20056341067107615913915
   PubMed Web of Science ®Google Scholar
• WeeCWKimKChieEKYuSJKimYJYoonJHPrognostic stratification and nomogram for survival prediction in hepatocellular carcinoma patients treated with radiotherapy for lymph node metastasisBr J Radiol20168910652016038327416997
   PubMed Web of Science ®Google Scholar
• RimCHKimCYYangDSYoonWSThe role of external beam radiotherapy for hepatocellular carcinoma patients with lymph node metastasis: a meta-analysis of observational studiesCancer Manag Res2018103305331530233246
   PubMed Web of Science ®Google Scholar
• RimCHKimCYYangDSComparison of radiation therapy modalities for hepatocellular carcinoma with portal vein thrombosis: a meta-analysis and systematic reviewRadiother Oncol2018129111212229233562
   PubMed Web of Science ®Google Scholar
• HouJZZengZCWangBLYangPZhangJYMoHFHigh dose radiotherapy with image-guided hypo-IMRT for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombi is more feasible and efficacious than conventional 3D-CRTJpn J Clin Oncol201646435736226802166
   PubMed Web of Science ®Google Scholar
• Abou-AlfaGKMeyerTChengALCabozantinib (C) versus placebo (P) in patients (PTS) with advanced hepatocellular carcinoma (HCC) who have received prior sorafenib: results from the randomized Phase III CELESTIAL trialJ Clin Oncol2018364 Suppl207
   Web of Science ®Google Scholar
• BruixJQinSMerlePRegorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, Phase 3 trialLancet201738910064566627932229
   PubMed Web of Science ®Google Scholar